HIV diagnosis becomes up to four times faster thanks to this invention

CARES Initiative Lab staff pippetting in Uganda

Africa’s poorest and most vulnerable can benefit from simple HIV test which monitors disease progression, enabling governments to deliver comprehensive treatment programs.

Prof Debbie Glencross is Director and Principle Pathologist in the Flow Cytometry unit of the Department of Haematology at the Charlotte Maxeke Johannesburg Academic Hospital, South Africa

Improving diagnostics in rural communities

Prof Debbie Glencross is Director and Principle Pathologist in the Flow Cytometry unit of the Department of Hematology at the Charlotte Maxeke Johannesburg Academic Hospital, South Africa. Her breakthrough PLG (Pan-Leukocyte Gating) method is easy to use and requires no specialist training, unlike conventional techniques for CD4 monitoring. Effective HIV treatment relies on clinicians having an accurate CD4 count for a patient. However, in many parts of rural Africa, the equipment and infrastructure simply isn’t available to test patients, get their blood samples to a lab, and then report the results. As Glencross explained: “Our objective is to empower smaller community laboratories so that they can extend the availability of PLG to meet demand, while still meeting the testing standards required by the National Health Laboratory Service (NHLS).”

“By making the testing process much simpler,

  both money and time can be saved.”

    CARES Initiative D. K. Glencross 

Speeding up CD4 cell counting

When counting CD4 cells, large labs differentiate between the types of white blood cells, count them and then work out the number of CD4 cells in each millionth of a liter of blood. While accurate, this method can be laborious.

In contrast, rather going through the time-consuming and costly process of isolating individual antibodies, Glencross’s approach uses a mathematical equation. She realized that using the white cell count as a stable reference point would eliminate the need for additional quality control steps, while still maintaining standards.

Working in partnership for maximum benefit

With the help of Beckman Coulter Life Sciences the Glencross’s PLG test was developed to use in conjunction the Aquios CL Flow Cytometer a more compact flow cytometry analyzer. Together the two technologies form the Aquios PLG test, a simple cytometry flow test which uses a two-color, pre-optimized reagent and provides both CD4 percentages and absolute counts. Consequently, the test enables rural healthcare workers with limited training to carry out diagnostics in community-based laboratories.

“A compact laboratory instrument is now available

 that offers high quality, automated CD4 counts

 in the near-patient setting.”

      CARES Initiative Aquios CL Operation 

Reporting time reduced by up to 400 per centi

Resource-poor communities not only save time, but also much needed healthcare costs. It was reported at a recent conference of the African Society of Laboratory Medicine that the time it took to report results when using the new test could be reduced by as much as 400% (with the median time down from 12-38 hours to just 4-13 hours)i.

Glencross concluded: “The cost of our HIV/AIDS burden makes it essential that we find new and more cost effective ways of providing CD4 monitoring. The PLG test simplifies flow cytometry so that it can be carried out in these smaller labs nearer the patient. This reduces the turnaround time so that people can have their results more quickly- but without increasing costs.”

 

Timely Treatment

Previously, blood samples had to be transported for several days to the larger flow cytometry centers. The combination of the simplified test and a powerful but compact analyzer changes this. Dr. Jeannine T. Holden, Beckman Coulter’s Director of Scientific Affairs, pointed out: “A compact laboratory instrument is now available that offers high quality, automated CD4 counts in the near-patient setting. The rapid turnaround time and ease of use enables doctors and patients to get results in well under an hour, so that timely treatment decisions can be made.”

" The rapid turnaround time and ease of use

  enables doctors and patients to get results in

  well under an hour, so that timely treatment

  decisions can be made.”
   CARES Initiative Vaccination by doctor inhouse